GlassScriptPhysician profile
Breanna Costa Perlmutter
NPI 1629501721
$2,155.01
in general payments reported to CMS, 2019-2025
8 companies · $518 in 2025
The $518 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $253 · 2024: $1,385 · 2025: $518.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,155 · Education: $1,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,155.01 |
| Education | $1,000.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,028.98 | 2024 | |
| Boston Scientific Corporation | $252.77 | 2023 | Spyglass Discover, Spyglass |
| Ethicon US, LLC | $227.32 | 2024-2025 | Echelon; Endopath, Ethicon, Evarrest |
| Dilon Technologies, INC. | $145.21 | 2024 | Hemoblast Bellows |
| Baxter Healthcare | $136.00 | 2025 | Floseal |
| Medtronic, INC. | $131.37 | 2025 | Signia |
| Angiodynamics, INC. | $117.00 | 2025 | Nanoknife |
| Solventum Corporation | $116.36 | 2024 | Abthera Advance, V.A.C.Instill, Prevena |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Breanna Perlmutter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.